Hopkins Lab, Cepheid Developing Methylated DNA Panel for Breast Cancer Dx, Monitoring | GenomeWeb

AUSTIN, Texas (GenomeWeb) – A research team from the Sidney Kimmel Cancer Center at Johns Hopkins University is collaborating with Cepheid to adapt a cell-free methylated DNA assay for early diagnosis and monitoring of breast cancer to a cartridge format that could run on Cepheid's GeneXpert system.

Sara Sukumar, who is spearheading the Hopkins team, discussed the effort at a corporate-sponsored workshop at the Association for Molecular Pathology annual meeting held here this week.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.